139 related articles for article (PubMed ID: 32404703)
21. [Positron emission tomography with 18F-fluorodeoxyglucose in patients with uterine sarcoma].
Rebollo Aguirre AC; Ramos Font C; Bellón Guardia ME; Cabello García D; Gallego Peinado M; Rodríguez Fernández A; Llamas Elvira JM
Rev Esp Med Nucl; 2007; 26(4):189-95. PubMed ID: 17662185
[TBL] [Abstract][Full Text] [Related]
22. Whole-body positron emission tomography with F-18 fluorodeoxyglucose for the detection of recurrence in uterine sarcomas.
Murakami M; Tsukada H; Shida M; Watanabe M; Maeda H; Koido S; Hirasawa T; Muramatsu T; Miyamoto T; Nasu S; Yasuda S; Kajiwara H; Yasuda M; Ide M
Int J Gynecol Cancer; 2006; 16(2):854-60. PubMed ID: 16681773
[TBL] [Abstract][Full Text] [Related]
23. Isolated splenic metastasis of ovarian cancer detected with 18F-FDG PET/CT.
Lee DH; Yoon JK; Lee SJ; Jo KS; Yoon SH; An YS
Clin Nucl Med; 2014 Apr; 39(4):349-51. PubMed ID: 23640230
[TBL] [Abstract][Full Text] [Related]
24. Preoperative [
Lee JW; Park JY; Lee HJ; Lee JJ; Moon SH; Kang SY; Cheon GJ; Chung HH
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(8):1309-1316. PubMed ID: 29492644
[TBL] [Abstract][Full Text] [Related]
25. Whole-body positron emission tomography with 18F-fluorodeoxyglucose is an effective method to detect extra-pelvic recurrence in uterine sarcomas.
Sung PL; Chen YJ; Liu RS; Shieh HJ; Wang PH; Yen MS; Wen KC; Shen SH; Lai CR; Yuan CC
Eur J Gynaecol Oncol; 2008; 29(3):246-51. PubMed ID: 18592788
[TBL] [Abstract][Full Text] [Related]
26. A rare localization of a common disease: Primary uterine Non-Hodgkin lymphoma mimicking leiomyosarcoma.
Goksel S; Karaman E; Karacin P; Ersöz Ş
J Cancer Res Ther; 2022; 18(4):1205-1207. PubMed ID: 36149191
[TBL] [Abstract][Full Text] [Related]
27. FDG PET/CT Findings of Primary Hepatic Leiomyosarcoma in an Immunocompetent Pediatric Patient.
Xie P; Zhuang H
Clin Nucl Med; 2017 Apr; 42(4):323-324. PubMed ID: 28166141
[TBL] [Abstract][Full Text] [Related]
28. Early detection of splenic metastasis of lung cancer by 18F-2-fluoro-2-deoxyglucose positron emission tomography.
Yen RF; Wu YW; Pan MH; Tzen KY
J Formos Med Assoc; 2005 Sep; 104(9):674-6. PubMed ID: 16276444
[TBL] [Abstract][Full Text] [Related]
29. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
30. Solitary Splenic Metastasis From Endometrial Carcinoma Revealed on FDG PET/CT.
Xiao L; Li Y; Li L
Clin Nucl Med; 2022 Dec; 47(12):e744-e745. PubMed ID: 35605058
[TBL] [Abstract][Full Text] [Related]
31. Whole-body staging of female patients with recurrent pelvic malignancies: Ultra-fast 18F-FDG PET/MRI compared to 18F-FDG PET/CT and CT.
Kirchner J; Sawicki LM; Suntharalingam S; Grueneisen J; Ruhlmann V; Aktas B; Deuschl C; Herrmann K; Antoch G; Forsting M; Umutlu L
PLoS One; 2017; 12(2):e0172553. PubMed ID: 28225831
[TBL] [Abstract][Full Text] [Related]
32. Reduction of glucose metabolic activity is more accurate than change in size at predicting histopathologic response to neoadjuvant therapy in high-grade soft-tissue sarcomas.
Evilevitch V; Weber WA; Tap WD; Allen-Auerbach M; Chow K; Nelson SD; Eilber FR; Eckardt JJ; Elashoff RM; Phelps ME; Czernin J; Eilber FC
Clin Cancer Res; 2008 Feb; 14(3):715-20. PubMed ID: 18245531
[TBL] [Abstract][Full Text] [Related]
33. Fluorodeoxyglucose positron emission tomography in leiomyosarcoma: imaging characteristics.
Punt SE; Eary JF; O'Sullivan J; Conrad EU
Nucl Med Commun; 2009 Jul; 30(7):546-9. PubMed ID: 19440162
[TBL] [Abstract][Full Text] [Related]
34. Sciatica as the first manifestation of a leiomyosarcoma of the buttock.
Benyahya E; Etaouil N; Janani S; Bennis R; Tarfeh M; Louhalia S; Mkinsi O
Rev Rhum Engl Ed; 1997 Feb; 64(2):135-7. PubMed ID: 9085450
[TBL] [Abstract][Full Text] [Related]
35. Combined PET/CT by 18F-FDOPA, 18F-FDA, 18F-FDG, and MRI correlation on a patient with Carney triad.
Papadakis GZ; Patronas NJ; Chen CC; Carney JA; Stratakis CA
Clin Nucl Med; 2015 Jan; 40(1):70-2. PubMed ID: 25423347
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic value of
Kassem TW; Abdelaziz O; Emad-Eldin S
Diagn Interv Imaging; 2017 Oct; 98(10):693-698. PubMed ID: 28734778
[TBL] [Abstract][Full Text] [Related]
37. Whole-body
Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T
Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514
[TBL] [Abstract][Full Text] [Related]
38. Splenic and multiple abdominal metastases of endometrial carcinoma detected with FDG-PET/CT.
Kara T; Kara PO; Gedik GK; Sari O
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):31-3. PubMed ID: 21737185
[TBL] [Abstract][Full Text] [Related]
39. [18F-FDG PET/CT with retrograde filling of the urinary bladder in the assessment of malignant pelvic disease].
García Vicente AM; Núñez García A; Palomar Muñoz A; Pilkington Woll JP; Bellón Guardia ME; González García B; Soriano Castrejón A
Rev Esp Med Nucl; 2011; 30(2):71-6. PubMed ID: 21334772
[TBL] [Abstract][Full Text] [Related]
40. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
